Journal of Biological Chemistry · 2004 · 146 citations · 49 references
Life SciencesCell BiologyMolecular BiologyApoptosisCell SignalingSignal TransductionApoptosis RegulationApoptotic SignalingHormone SignalingOsteocyte BiologyProtein Kinase CascadesSteroid Hormone SignalingAdenylate Cyclase SignalingCamp-protein Kinase A SignalingErk SignalingExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingProtein Kinase A SignalingProtein Subcellular LocalizationSubcellular Protein Localization
Sex steroids exert anti-apoptotic effects on osteoblasts/osteocytes but exert pro-apoptotic effects on osteoclasts, in both cases requiring activation of the extracellular signal-regulated kinases (ERKs). To explain the mechanistic basis of this divergence, we searched for differences in the kinetics of phosphorylation and/or in the subcellular localization of ERKs in response to 17beta-estradiol in the two cell types. In contrast to its transient effect on ERK phosphorylation in osteocytic cells (return to base line by 30 min), 17beta-estradiol-induced ERK phosphorylation in osteoclasts was sustained for at least 24 h following exposure to the hormone. Conversion of sustained ERK phosphorylation to transient, by means of cholera toxin-induced activation of the adenylate cyclase/cAMP/protein kinase A pathway, abrogated the pro-apoptotic effect of 17beta-estradiol on osteoclasts. Conversely, prolongation of ERK activation in osteocytes, by means of leptomycin B-induced inhibition of ERK export from the nucleus or overexpression of a green fluorescent protein-ERK2 mutant that resides permanently in the nucleus, converted the anti-apoptotic effect of 17beta-estradiol to a pro-apoptotic one. These findings indicate that the kinetics of ERK phosphorylation and the length of time that phospho-ERKs are retained in the nucleus are responsible for pro-versus anti-apoptotic effects of estrogen on different cell types of bone and perhaps their many other target tissues.
49
A short amino acid sequence able to specify nuclear location
Daniel Kalderon, Bruce Roberts, William D. Richardson et al. · Cell · 1984 · 2.6K citations
Robert S. Weinstein, R L Jilka, A. M. Parfitt et al. · Journal of Clinical Investigation · 1998 · 1.8K citations · Full text
Medicine, Endocrinology, Aging +16
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Robert L. Jilka, Giao Hangoc, Giuseppe Girasole et al. · Science · 1992 · 1.5K citations
Medicine, Endocrinology, Immunology +17
Transformation of Mammalian Cells by Constitutively Active MAP Kinase Kinase
Sam J. Mansour, Wayne T. Matten, April S. Hermann et al. · Science · 1994 · 1.4K citations
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
Stavroula Kousteni, Teresita Bellido, Lilian I. Plotkin et al. · Cell · 2001 · 1.1K citations · Full text